CyFlow™ MPO FITC
Application: | Flow cytometry |
Clonality: | monoclonal |
Format/Fluorochrome: | FITC |
Target Species: | Human |
Laser: | Blue |
Excitation Maximum: | 490 to 495 nm |
Emission Maximum: | 518 nm |
Source Species: | Mouse |
Field of Interest: | Immunophenotyping, Others |
Isotype: | IgG1 |
Antigen: | Myeloperoxidase |
Clone: | MPO421-8B2 |
Regulatory Status: | CE IVD |
Order number: | CA178336 |
CE IVD labeled reagents are sold in European Union countries and in countries where they are compliant with local regulation (not in Canada, not in the United States). Availability may vary by location, depending on regulatory status. Please inquire.
Wish ListMyeloperoxidase (MPO) is a heme enzyme that is localized in azurophilic (primary) granules of myeloid cells and its synthesis occurs at an early stage of differentiation. The mature myeloperoxidase is a tetramer composed of two light (12 kDa) and two heavy (60 kDa) chains. This enzyme uses hydrogen peroxide to oxidize numerous substrates, including serotonin, melatonin or chloride, to produce reactive free radicals that contribute to immune reactions of myeloid cells against pathogens. Myeloperoxidase functions not only in host defense by mediating efficient microbial killing but also can contribute to progressive tissue damage in chronic inflammatory states such as atherosclerosis or acute pancreatitis.
Technical Data Sheet
- CyFlow MPO FITC (MPO421-8B2) CN934321 TDS RUO.pdf
- CyFlow™ MPO FITC (MPO421-8B2) AL616617 TDS US,CA EN.pdf
- CyFlow MPO FITC (MPO421-8B2) AL616617 TDS ASR EN.pdf
Instruction for Use
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU CZ CZ.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU DK DK.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU GR EL.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU IT IT.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU NL NL.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU NO NO.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU PL PL.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU RU RU.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU SE SV.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU SK SK.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU TR TR.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU CZ CZ.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU DE DE.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU ES ES.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU FR FR.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU GB EN.pdf
- CyFlow MPO FITC (MPO421-8B2) BD485396 IFU PT PT.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU DE DE.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU DK DK.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU ES ES.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU FR FR.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU GB EN.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU GR EL.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU IT IT.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU NL NL.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU NO NO.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU PL PL.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU PT PT.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU RU RU.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU SE SV.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU SK SK.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU TR TR.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU BG BG.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU HR HR.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU RO RO.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU SI SL.pdf
- CyFlow MPO FITC (MPO421-8B2) CA178336 IFU RS SR.pdf
ECDoC
Certificate Of Analysis
- CyFlow MPO FITC AL616617 COA 902347.pdf
- CyFlow MPO FITC BD485396 COA 902347.pdf
- CyFlow MPO FITC AL616617 COA 904442.pdf
- CyFlow MPO FITC CA178336 COA 904442.pdf
- CyFlow MPO FITC AL616617 COA 904726.pdf
- CyFlow MPO FITC CA178336 COA 904726.pdf
- CyFlow MPO FITC CA178336 COA 907179.pdf
- CyFlow MPO FITC AL616617 COA 907179.pdf
Antigen: | CD1a |
Clone: | SK9 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 100 tests |
Antigen: | CD1a |
Clone: | SK9 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 100 tests |
Antigen: | CD1a |
Clone: | SK9 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 100 tests |
Antigen: | CD1a |
Clone: | SK9 |
Application: | Flow cytometry, Immunoprecipitation |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |
Antigen: | CD1b |
Clone: | SN13 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 100 tests |
Antigen: | CD1b |
Clone: | SN13 |
Application: | Flow cytometry, Immunohistochemistry, Immunoprecipitation |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |
Antigen: | CD1c |
Clone: | L161 |
Application: | Flow cytometry |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 100 tests |
Antigen: | CD1c |
Clone: | L161 |
Application: | Flow cytometry, Immunohistochemistry, Immunoprecipitation |
Regulatory Status: | RUO |
Target Species: | Human | Quantity: | 0.1 mg |